The Impact of Enterococcus spp. in the Immunocompromised Host: A Comprehensive Review
- PMID: 38787261
- PMCID: PMC11124283
- DOI: 10.3390/pathogens13050409
The Impact of Enterococcus spp. in the Immunocompromised Host: A Comprehensive Review
Abstract
The immunocompromised host is usually vulnerable to infectious diseases due to broad-spectrum treatments and immunological dysregulation. The Enterococcus genus consists of normal gut commensals, which acquire a leading role in infective processes among individuals with compromised immune systems. These microorganisms may express a potential virulence and resistance spectrum, enabling their function as severe pathogens. The Enterococcus spp. infections in immunocompromised hosts appear to be difficult to resolve due to the immunological response impairment and the possibility of facing antimicrobial-resistant strains. As regards the related risk factors, several data demonstrated that prior antibiotic exposure, medical device insertion, prolonged hospitalization and surgical interventions may lead to Enterococcus overgrowth, antibiotic resistance and spread among critical healthcare settings. Herein, we present a comprehensive review of Enterococcus spp. in the immunocompromised host, summarizing the available knowledge about virulence factors, antimicrobial-resistance mechanisms and host-pathogen interaction. The review ultimately yearns for more substantial support to further investigations about enterococcal infections and immunocompromised host response.
Keywords: Enterococcus; immunocompromised host; infection; pathogenicity.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Lupia T., Roberto G., Scaglione L., Shbaklo N., De Benedetto I., Scabini S., Mornese Pinna S., Curtoni A., Cavallo R., De Rosa F.G., et al. Clinical and microbiological characteristics of bloodstream infections caused by Enterococcus spp. within internal medicine wards: A two-year single-centre experience. Intern. Emerg. Med. 2022;17:1129–1137. doi: 10.1007/s11739-022-02926-w. - DOI - PMC - PubMed
-
- Ha S., Huh K., Chung D.R., Ko J.-H., Cho S.Y., Huh H.J., Lee N.Y., Kang C.-I., Peck K.R., Song J.-H., et al. Efficacy of teicoplanin in bloodstream infections caused by Enterococcus faecium: Posthoc analysis of a nationwide surveillance. Int. J. Infect. Dis. 2022;122:506–513. doi: 10.1016/j.ijid.2022.06.029. - DOI - PubMed
-
- Berge A., Morenius C., Petropoulos A., Nilson B., Rasmussen M. Epidemiology, bacteriology, and clinical characteristics of HACEK bacteremia and endocarditis: A population-based retrospective study. Eur. J. Clin. Microbiol. Infect. Dis. 2021;40:525–534. doi: 10.1007/s10096-020-04035-y. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
